Picture courtesy Xinhua
New Delhi: The World Health Organisation (WHO) on Tuesday, gave authorisation to China’s Sinovac Biotech Ltd. The WHO recommended its use for people aged 18 and older in a two-dose schedule with a spacing of two to four weeks between shots.
The emergency use listing granted to Sinovac’s shot is the second given to a Chinese COVID vaccine. Earlier in May, the state-owned Sinopharm Group Co. secured WHO’s nod for emergency use.
Sinovac has shipped 380 million doses to countries and regions ranging from Hong Kong to Zimbabwe since late last year, Hindustan Times reported.
The shot, dubbed CoronaVac, has the lowest efficacy rate reported from clinical trials among the frontrunner wave of vaccines. It was found to be just 50.7% effective in preventing symptomatic COVID in a trial in Brazil, barely crossing the minimum threshold required by drug regulators around the world. However, in a recent study of around 130,000 Indonesian health workers, it protected 94% against symptomatic infection, 96% against hospitalization, and 98% against death, the report added.
Mumbai: Television actress Hina Khan, who is battling breast cancer, recently met host Salman Khan…
Mumbai: Following reports of his alleged link-up with bassist Mohini Dey, renowned music composer AR…
Mumbai: The love story of actors Tamannaah Bhatia and Vijay Varma has not been clandestine.…
Puri: Shree Jagannath Temple Administration (SJTA) has received the report of the Ratna Bhandar’s GPR-GPS…
With his debut novel ‘The Other Side of the Rainbow’ published recently, Niranjan Nayak, an…
Bhubaneswar: Odisha outplayed Chhattisgarh 4-1 on Saturday to seal a berth in the final round…
Mumbai: The Telangana government’s notice barring him from singing songs promoting alcohol and drugs at…
Bhubaneswar: Prime Minister Narendra Modi will participate in the ‘Odisha Parba 2024’ programme on Sunday…